Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

948 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lionheart LincRNA alleviates cardiac systolic dysfunction under pressure overload.
Kuwabara Y, Tsuji S, Nishiga M, Izuhara M, Ito S, Nagao K, Horie T, Watanabe S, Koyama S, Kiryu H, Nakashima Y, Baba O, Nakao T, Nishino T, Sowa N, Miyasaka Y, Hatani T, Ide Y, Nakazeki F, Kimura M, Yoshida Y, Inada T, Kimura T, Ono K. Kuwabara Y, et al. Among authors: inada t. Commun Biol. 2020 Aug 13;3(1):434. doi: 10.1038/s42003-020-01164-0. Commun Biol. 2020. PMID: 32792557 Free PMC article.
Impact of statin therapy on late target lesion revascularization after sirolimus-eluting stent implantation (from the CREDO-Kyoto Registry Cohort-2).
Natsuaki M, Nakagawa Y, Morimoto T, Ono K, Shizuta S, Furukawa Y, Kadota K, Iwabuchi M, Kato Y, Suwa S, Inada T, Doi O, Takizawa A, Nobuyoshi M, Kita T, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators. Natsuaki M, et al. Among authors: inada t. Am J Cardiol. 2012 May 15;109(10):1387-96. doi: 10.1016/j.amjcard.2012.01.350. Epub 2012 Feb 28. Am J Cardiol. 2012. PMID: 22381164 Clinical Trial.
Intensity of statin therapy, achieved low-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after coronary revascularization. Perspectives from the CREDO-Kyoto registry cohort-2.
Natsuaki M, Furukawa Y, Morimoto T, Nakagawa Y, Ono K, Kaburagi S, Inada T, Mitsuoka H, Taniguchi R, Nakano A, Kita T, Sakata R, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Natsuaki M, et al. Among authors: inada t. Circ J. 2012;76(6):1369-79. doi: 10.1253/circj.cj-11-1356. Epub 2012 Mar 15. Circ J. 2012. PMID: 22447012 Free article.
Short versus prolonged dual antiplatelet therapy duration after bare-metal stent implantation: 2-month landmark analysis from the CREDO-Kyoto registry cohort-2.
Natsuaki M, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Ando K, Shiomi H, Toyota T, Watanabe H, Ono K, Shizuta S, Tamura T, Inoko M, Inada T, Shirotani M, Matsuda M, Aoyama T, Onodera T, Suwa S, Takeda T, Inoue K, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Natsuaki M, et al. Among authors: inada t. Cardiovasc Interv Ther. 2018 Jan;33(1):23-34. doi: 10.1007/s12928-016-0429-6. Epub 2016 Sep 19. Cardiovasc Interv Ther. 2018. PMID: 27646646
Different clinical outcomes in patients with asymptomatic severe aortic stenosis according to the stage classification: Does the aortic valve area matter?
Kitai T, Taniguchi T, Morimoto T, Toyota T, Izumi C, Kaji S, Kim K, Saito N, Nagao K, Inada T, Minamino-Muta E, Kato T, Inoko M, Ishii K, Koyama T, Sakata R, Furukawa Y, Kimura T; CURRENT AS registry Investigators. Kitai T, et al. Among authors: inada t. Int J Cardiol. 2017 Feb 1;228:244-252. doi: 10.1016/j.ijcard.2016.11.092. Epub 2016 Nov 11. Int J Cardiol. 2017. PMID: 27865193
MicroRNA-33 Controls Adaptive Fibrotic Response in the Remodeling Heart by Preserving Lipid Raft Cholesterol.
Nishiga M, Horie T, Kuwabara Y, Nagao K, Baba O, Nakao T, Nishino T, Hakuno D, Nakashima Y, Nishi H, Nakazeki F, Ide Y, Koyama S, Kimura M, Hanada R, Nakamura T, Inada T, Hasegawa K, Conway SJ, Kita T, Kimura T, Ono K. Nishiga M, et al. Among authors: inada t. Circ Res. 2017 Mar 3;120(5):835-847. doi: 10.1161/CIRCRESAHA.116.309528. Epub 2016 Dec 5. Circ Res. 2017. PMID: 27920122
High- Versus Low-Gradient Severe Aortic Stenosis: Demographics, Clinical Outcomes, and Effects of the Initial Aortic Valve Replacement Strategy on Long-Term Prognosis.
Taniguchi T, Morimoto T, Shiomi H, Ando K, Kanamori N, Murata K, Kitai T, Kawase Y, Izumi C, Miyake M, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Inada T, Nagao K, Murakami T, Takeuchi Y, Yamane K, Toyofuku M, Ishii M, Minamino-Muta E, Kato T, Inoko M, Ikeda T, Komasa A, Ishii K, Hotta K, Higashitani N, Kato Y, Inuzuka Y, Maeda C, Jinnai T, Morikami Y, Saito N, Minatoya K, Kimura T; CURRENT AS Registry Investigators. Taniguchi T, et al. Among authors: inada t. Circ Cardiovasc Interv. 2017 May;10(5):e004796. doi: 10.1161/CIRCINTERVENTIONS.116.004796. Circ Cardiovasc Interv. 2017. PMID: 28500139
Impact of the left ventricular mass index on the outcomes of severe aortic stenosis.
Minamino-Muta E, Kato T, Morimoto T, Taniguchi T, Inoko M, Haruna T, Izumi T, Miyamoto S, Nakane E, Sasaki K, Funasako M, Ueyama K, Shirai S, Kitai T, Izumi C, Nagao K, Inada T, Tada E, Komasa A, Ishii K, Saito N, Sakata R, Minatoya K, Kimura T. Minamino-Muta E, et al. Among authors: inada t. Heart. 2017 Dec;103(24):1992-1999. doi: 10.1136/heartjnl-2016-311022. Epub 2017 Jul 6. Heart. 2017. PMID: 28684442 Free PMC article.
948 results